Belpointe Asset Management LLC Decreases Stock Holdings in HealthEquity, Inc. $HQY

Belpointe Asset Management LLC trimmed its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 21.2% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,736 shares of the company’s stock after selling 1,814 shares during the quarter. Belpointe Asset Management LLC’s holdings in HealthEquity were worth $706,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Ieq Capital LLC grew its position in shares of HealthEquity by 4.4% in the first quarter. Ieq Capital LLC now owns 2,945 shares of the company’s stock valued at $260,000 after purchasing an additional 123 shares in the last quarter. Xponance Inc. grew its position in shares of HealthEquity by 1.1% in the first quarter. Xponance Inc. now owns 12,412 shares of the company’s stock valued at $1,097,000 after purchasing an additional 136 shares in the last quarter. Fifth Third Bancorp grew its position in shares of HealthEquity by 17.5% in the first quarter. Fifth Third Bancorp now owns 955 shares of the company’s stock valued at $84,000 after purchasing an additional 142 shares in the last quarter. Sheets Smith Wealth Management grew its position in shares of HealthEquity by 1.9% in the second quarter. Sheets Smith Wealth Management now owns 8,419 shares of the company’s stock valued at $882,000 after purchasing an additional 157 shares in the last quarter. Finally, AlphaQ Advisors LLC grew its position in shares of HealthEquity by 5.1% in the first quarter. AlphaQ Advisors LLC now owns 3,430 shares of the company’s stock valued at $303,000 after purchasing an additional 165 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at HealthEquity

In related news, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the transaction, the executive vice president owned 49,795 shares in the company, valued at $4,392,416.95. The trade was a 3.45% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Delano Ladd sold 6,000 shares of the business’s stock in a transaction dated Friday, September 19th. The shares were sold at an average price of $94.11, for a total value of $564,660.00. Following the transaction, the executive vice president owned 79,456 shares in the company, valued at approximately $7,477,604.16. This represents a 7.02% decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on HQY shares. KeyCorp dropped their price objective on HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a research note on Wednesday. Raymond James Financial reissued a “strong-buy” rating and set a $120.00 price objective (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Jefferies Financial Group lifted their price target on HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research note on Wednesday, September 3rd. Barrington Research reiterated an “outperform” rating and issued a $125.00 price objective on shares of HealthEquity in a report on Friday, August 29th. Finally, Royal Bank Of Canada lifted their price objective on HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus price target of $121.31.

HealthEquity Stock Up 4.1%

HQY opened at $92.09 on Thursday. The company has a market cap of $7.93 billion, a P/E ratio of 55.81, a P/E/G ratio of 1.27 and a beta of 0.47. The business’s 50-day moving average price is $91.71 and its 200-day moving average price is $93.82. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 12 month low of $74.07 and a 12 month high of $116.65.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.